September 20, 2012—Twenty one of the 25 states that use managed care organizations (MCOs) to administer their Medicaid pharmacy benefit have procedures to exclude 340B claims from their Medicaid MCO drug rebate requests, a new report has found.
The report, by the U.S. Department of Health and Human Services Office of Inspector General (OIG), focuses primarily on what states are doing to collect rebates on Medicaid managed care drugs.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)